Skip to content
Trial Eligibility
Menu

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

NCT04899544

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The aim of this clinical trial is to compare the efficacy of a 16-week center-based Pivotal Response Treatment (PRT-C) versus home-based Pivotal Response Treatment (PRT-H) in targeting social communication deficits in young children with autism spectrum disorder (ASD) with significant language delay. The two groups will also be compared to a control group that consists of children who are receiving treatment as usual (TAU).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Autism
  • Autism Spectrum Disorder
  • ASD

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
2 to 5 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Stanford University
Last updated on ClinicalTrials.gov
June 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Stanford University School of Medicine · Stanford, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.